Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 236-243
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.236
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.236
Bacterial species/subspecies | Straindesignation | Type of isolate, sourceand/or reference |
Lactobacillus salivariussubsp salivarius | Ls33 | Commercial strain |
Lactobacillus rhamnosus | Lr32 | Commercial strain |
Lactobacillus casei | Bl23 | ATCC1 393, plasmid-cured |
Lactobacillus acidophilus | NCFM | Human, commercial strain |
Lactobacillus acidophilus | IPL3 908 | Commercial isolate |
Lactobacillus plantarum | NCIMB 8826 | Human, NCIMB2 collection |
Lactobacillus plantarum | Lp115 | Commercial strain |
Bifidobacterium animalis subsp lactis | BL04 | Commercial strain |
Bifidobacterium animalis subsp lactis | BI07 | Commercial strain |
Bifidobacterium bifidum | BB02 | Commercial strain |
Lactococcus lactis | MG1363 | Cheese starter derivative[42] |
Streptococcus gordonii | V288 (Challis) | ATCC1 35105 |
Escherichia coli (non-pathogenic) | TG1 | Cloning strain[43] |
-
Citation: Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B. Correlation between
in vitro andin vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 2007; 13(2): 236-243 - URL: https://www.wjgnet.com/1007-9327/full/v13/i2/236.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i2.236